Sonoma Pharmaceuticals, Inc. Made Headway
Thu, Aug 19, 2021 at 05:30 PM
Sonoma Pharmaceuticals, Inc. (SNOA:NASDAQ) rocketted at $8.15, representing a gain of 50.6%. On Wed, Aug 18, 2021, SNOA:NASDAQ hit a New 2-Week Intraday Low of $5.27. The stock appeared on our News Catalysts scanner on Mon, Aug 16, 2021 at 04:51 PM in the 'EARNINGS' category. From Wed, Aug 04, 2021, the stock recorded 30.00% Up Days and 36.36% Green Days
The stock spiked on Tue, Jul 13, 2021 at $9.73 with a volume of 1M+.
About Sonoma Pharmaceuticals, Inc. (SNOA:NASDAQ)
Sonoma Pharmaceuticals Inc is a speciality pharmaceutical company. It develops,identifies and commercialises therapies for dermatologic diseases.
Top 10 Gainers:
- Sonnet BioTherapeutics Holdings, Inc. (SONN:NASDAQ), 63.74%
- Sonoma Pharmaceuticals, Inc. (SNOA:NASDAQ), 50.65%
- DLO (DLO:NASDAQ), 26.68%
- China Liberal Education Holdings Limited (CLEU:NASDAQ), 22.71%
- ENSC (ENSC:NASDAQ), 22.36%
- DATS (DATS:NASDAQ), 21.78%
- Macy's, Inc. (M:NYSE), 19.59%
- DNUT (DNUT:NASDAQ), 14.08%
- STVN (STVN:NYSE), 13.53%
- InVivo Therapeutics Holdings Corp. (NVIV:NASDAQ), 12.31%